Clinical Trials
26 trialsNatural History Study of Early Life Exposures in Agriculture (ELEA)
National Institutes of Health Clinical Center (CC)
A Multilevel Intervention to Increase Colorectal Cancer Screening Tests in Patients With Abnormal Fecal Immunochemical Test Results, PROACT Trial
Fred Hutchinson Cancer Center
PRO-GENE-COLON
Endeavor Health
DESCENT-1
A2 Biotherapeutics Inc.
Choose It and Use It: Choice, Implementation Intentions and At-Home Colorectal Cancer Screening
Michigan State University
CRC URomLS
University of Roma La Sapienza
Impact of Dietary Intervention on Inflammation and Microbiome Composition Post-Colonoscopy
University of California, San Diego
SAFE-3CV
SafeHeal Inc
MRD-positive Colorectal Cancer Patients Combined With Personalized Immune Regulation Diagnosis
Second Affiliated Hospital of Wenzhou Medical University
StomaFUNQ
Sahlgrenska University Hospital
NIVO402025
Blokhin's Russian Cancer Research Center
RISCC
Indiana University
IMPACTT
University of California, San Francisco
Mechanical Bowel Preparation With or Without Oral Antibiotics in Left Sided Colorectal Cancer Surgery
Shaukat Khanum Memorial Cancer Hospital & Research Centre
Evaluating the Efficacy of the eNav Toolkit to Improve Colorectal Cancer Screening
Icahn School of Medicine at Mount Sinai
Tattooing
Seoul St. Mary's Hospital
Reinforced Versus Conventional Anastomosis in Laparoscopic Low Rectal Cancer Resection: A Comparative Study
Shanghai 10th People's Hospital
Comparison of Efficacy and Safety Between FOLFOX-6 and CAPOX in Metastatic Colorectal Carcinoma
Allama Iqbal Medical College
Initial Testing of a Behavioral Intervention About Genetic Services for Families at Risk of Lynch Syndrome
University of Alabama at Birmingham
Individually Tailored Strategies for the Precision Prevention of Gastric Cancer and Colorectal Cancer in the Community
National Taiwan University Hospital
SPARROW
Acibadem University
PROOF
NYU Langone Health
IDecide
Indiana University
AI-informed Colorectal Cancer (CRC) Screening Navigation vs. Standard of Care Among Screening-naive Penn Medicine Patients 45-49 Years Old to Increase CRC Screening Uptake
Abramson Cancer Center at Penn Medicine
Head to Head Trial of Mailed Cologuard to Mailed FIT
University of California, San Diego
XS-03-II201
NovaOnco Therapeutics Co., Ltd.